Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: StemRIM

Market Cap 20.12B 125M 109M 100M 94.43M 177M 11.78B 178M 1.19B 464M 5.81B 469M 459M P/E 2024
-13.6x
P/E 2025 -10.2x
Enterprise Value 13.13B 81.54M 71.05M 65.49M 61.6M 115M 7.68B 116M 779M 303M 3.79B 306M 300M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
47.55%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 65 2022-09-30
Chief Executive Officer 58 2023-10-24
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 65 2007-01-31
Director/Board Member 58 2019-02-28
Director/Board Member 54 2019-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 125M
+0.33%-0.25%+18.76%-22.11% 62.05B
+0.28%-9.24%+58.26%+196.32% 54.45B
+4.38%+43.00%+43.00%+43.00% 43.09B
+7.62%+8.19%-51.27%-59.11% 36.37B
-1.05%-1.69%+55.35%-33.92% 29.02B
+3.50%+28.85%+151.81%-50.31% 25.38B
-0.78%-8.91%+43.87%+55.34% 19.62B
+1.74%+4.39%-3.12%+107.49% 16.89B
-0.05%+0.41%+56.32%+94.95% 15.93B
Average +1.58%+3.20%+41.44%+36.85% 33.64B
Weighted average by Cap. +1.86%+2.21%+37.94%+36.90%

Financials

2024 2025
Net sales - -
Net income -2.02B -12.56M -10.94M -10.09M -9.49M -17.75M -1.18B -17.88M -120M -46.61M -583M -47.15M -46.14M -1.93B -11.98M -10.44M -9.62M -9.05M -16.94M -1.13B -17.06M -115M -44.47M -557M -44.98M -44.01M
Net Debt -8.41B -52.24M -45.52M -41.96M -39.47M -73.84M -4.92B -74.36M -499M -194M -2.43B -196M -192M -6.99B -43.45M -37.85M -34.9M -32.82M -61.41M -4.09B -61.84M -415M -161M -2.02B -163M -160M
Logo StemRIM
StemRIM Inc. is a Japan-based company mainly engaged in the regenerative medicine business. The Company is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.
Employees
45
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!